We are live on ! Find out more
EntryPoint Capital

EntryPoint Capital Portfolio holdings

AUM $365M Turnover 57.12%
1-Year Est. Return 16.27%
This Fund
S&P 500
This Quarter Est. Return
+2.29%
1 Year Est. Return
+16.27%
3 Year Est. Return
+40.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$7.21M
Cap. Flow
+$6.18M
Cap. Flow %
5.54%
Top 10 Hldgs %
3.56%
Holding
1,843
New
512
Increased
412
Reduced
454
Closed
458
Avg Time Held
0.2 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
UIS icon
Unisys
UIS
+$562K
2
FLGT icon
Fulgent Genetics
FLGT
+$385K
3
SDGR icon
Schrodinger
SDGR
+$384K
4
AGYS icon
Agilysys
AGYS
+$367K
5
RIOT icon
Riot Platforms
RIOT
+$344K

Sector Composition

Rank Sector Weight
1 Healthcare 20.54%
2 Industrials 17.17%
3 Technology 16.76%
4 Financials 12.55%
5 Consumer Discretionary 12.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GXO icon
1
GXO Logistics
GXO
$5.89B
$470K 0.42%
8,748
+5,991
+217% +$324K
2023 Q4
1 quarter
UIS icon
2
Unisys
UIS
$182M
$454K 0.41%
+92,556
New +$562K
2024 Q1
0 quarters
SDGR icon
3
Schrodinger
SDGR
$1.72B
$428K 0.38%
15,853
+13,742
+651% +$384K
2023 Q4
1 quarter
LEG icon
4
DELISTED
Leggett & Platt
LEG
$408K 0.37%
21,308
+13,533
+174% +$294K
2023 Q4
1 quarter
STRO icon
5
Sutro Biopharma
STRO
$143M
$394K 0.35%
+6,968
New +$308K
2024 Q1
0 quarters
AGYS icon
6
Agilysys
AGYS
$3.12B
$382K 0.34%
+4,537
New +$367K
2024 Q1
0 quarters
RIOT icon
7
Riot Platforms
RIOT
$6.09B
$366K 0.33%
29,877
+26,434
+768% +$344K
2023 Q4
1 quarter
REVG icon
8
DELISTED
REV Group
REVG
$362K 0.32%
16,367
+15,618
+2,085% +$292K
2023 Q4
1 quarter
TSHA icon
9
Taysha Gene Therapies
TSHA
$1.21B
$353K 0.32%
122,905
-168,711
-58% -$352K
2023 Q4
1 quarter
HELE icon
10
Helen of Troy
HELE
$806M
$350K 0.31%
3,037
+2,155
+244% +$257K
2023 Q4
1 quarter
CORT icon
11
Corcept Therapeutics
CORT
$6.88B
$347K 0.31%
13,786
+4,802
+53% +$113K
2023 Q4
1 quarter
FLGT icon
12
Fulgent Genetics
FLGT
$674M
$339K 0.3%
15,622
+15,519
+15,067% +$385K
2023 Q4
1 quarter
ATRC icon
13
AtriCure
ATRC
$2.82B
$339K 0.3%
11,138
+3,986
+56% +$134K
2023 Q4
1 quarter
JNJ icon
14
Johnson & Johnson
JNJ
$651B
$339K 0.3%
2,141
+424
+25% +$67.5K
2023 Q4
1 quarter
GLDD icon
15
DELISTED
Great Lakes Dredge & Dock
GLDD
$335K 0.3%
+38,261
New +$315K
2024 Q1
0 quarters
POWL icon
16
Powell Industries
POWL
$5.4B
$332K 0.3%
7,005
-594
-8% -$25.4K
2023 Q4
1 quarter
ACLS icon
17
Axcelis
ACLS
$2.79B
$330K 0.3%
2,963
+1,050
+55% +$125K
2023 Q4
1 quarter
PBYI icon
18
Puma Biotechnology
PBYI
$364M
$329K 0.29%
+61,991
New +$334K
2024 Q1
0 quarters
MBI icon
19
MBIA
MBI
$215M
$324K 0.29%
+47,986
New +$304K
2024 Q1
0 quarters
XNCR icon
20
Xencor
XNCR
$2.5B
$317K 0.28%
14,306
-1,113
-7% -$24K
2023 Q4
1 quarter
TBBK icon
21
Bancorp
TBBK
$1.76B
$315K 0.28%
9,415
+5,581
+146% +$222K
2023 Q4
1 quarter
AAPL icon
22
Apple
AAPL
$4.98T
$312K 0.28%
1,822
+1,470
+418% +$267K
2023 Q4
1 quarter
AEIS icon
23
Advanced Energy
AEIS
$7.7B
$312K 0.28%
+3,058
New +$312K
2024 Q1
0 quarters
HMN icon
24
Horace Mann Educators
HMN
$2.12B
$307K 0.28%
8,310
+7,582
+1,041% +$269K
2023 Q4
1 quarter
ZD icon
25
Ziff Davis
ZD
$1.63B
$307K 0.28%
4,875
+2,444
+101% +$162K
2023 Q4
1 quarter

Similar funds

EntryPoint Capital's Q1 2024 Portfolio in Review

As of Q1 2024, EntryPoint Capital held 1,843 positions worth $112M, up 6.9% from $104M the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

EntryPoint Capital deployed $6.18M of net new capital in Q1 2024, opening 512 new positions and adding to 412 existing holdings. Its largest new stake was Unisys: 92,556 shares worth $454K.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was NextDecade, an estimated $565K trimmed.

  • EntryPoint Capital's largest Q1 2024 buy was Unisys: 92,556 shares worth $454K.
  • EntryPoint Capital added most to Fulgent Genetics in Q1 2024, an estimated $385K increase.
  • EntryPoint Capital's biggest Q1 2024 reduction was NextDecade, cutting an estimated $565K.
  • EntryPoint Capital fully exited American Well in Q1 2024, selling an estimated $535K.
  • EntryPoint Capital's ten largest holdings make up 3.6% of its $112M portfolio in Q1 2024.
  • EntryPoint Capital opened 512 new positions and closed 458 in Q1 2024.
  • EntryPoint Capital's portfolio value rose 6.9% quarter-over-quarter to $112M.

Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.